9 completed, 2 not yet recruiting, 2 recruiting, 2 unknown. 16 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Completed 9, Not yet recruiting 2, Recruiting 2, Unknown 2, Active not recruiting 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Minoxidil: new trials by email Literature Review of Minoxidil trials Research Report on Minoxidil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Minoxidil oral solution, Placebo oral solution - Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 3 | Not yet recruiting | Eurofarma Laboratorios S.A. | 372 | 2027-01-31 | 2026-11-06 |
| Androgenic Alopecia TH07 Clinical Trial TH07, Minoxidil 5% Topical Solution, Placebo - Androgenic Alopecia | Phase 3 | Recruiting | Triple Hair Inc | 420 | 2026-04-01 | 2026-03-16 |
| Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia Minoxidil 5 % Topical Spray, minoxidil, Placebo Spray - Androgenic Alopecia | Phase 3 | Not yet recruiting | Sheikh Zayed Federal Postgraduate Medical Institute | 200 | 2025-12-20 | 2025-12-10 |
| Efficacy & Safety of Minoxidil SL Tablets in Men With AGA Minoxidil, Placebo - Androgenetic Alopecia, Male Pattern Baldness | Phase 3 | Completed | Samson Clinical Operations Pty Ltd | 142 | 2025-07-14 | 2026-05-18 |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia Minoxidil Tablets, Minoxidil Topical, Placebo oral tablet - Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | Active not recruiting | Industrial Farmacéutica Cantabria, S.A. | 520 | 2024-10-17 | 2026-11-02 |
| Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men Minoxidil 5% Topical Solution, microneedling - Androgenetic Alopecia | Phase 3 | Completed | Universitas Indonesia | 36 | 2023-06-01 | 2023-09-28 |
| Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia Finasteride, Minoxidil - Androgenetic Alopecia | Phase 2 / Phase 3 | Unknown | Universitas Indonesia | 40 | 2023-05-01 | 2023-09-22 |
| Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia Finlândia Association + finasteride placebo, Minoxidil + finasteride - Androgenetic Alopecia | Phase 3 | Recruiting | EMS | 190 | 2023-02-02 | 2025-12-08 |
| Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil, Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil, Placebo and 5% Minoxidil - Alopecia, Androgenetic, Hair Loss/Baldness | Phase 3 | Completed | Dr. dr. Lili Legiawati, SpKK(K) | 37 | 2021-10-11 | 2022-03-25 |
| Topical Cetirizine in Androgenetic Alopecia in Females Topical cetirizine, Placebo, Topical minoxidil - Androgenetic Alopecia | Phase 2 / Phase 3 | Completed | Cairo University | 66 | 2020-07-25 | 2023-02-08 |
| Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5% Topical Herbal Solution, Topical Minoxidil 5% - Androgenetic Alopecia | Phase 3 | Completed | Farid Masoud | 24 | 2018-11-28 | 2020-03-16 |
| Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients Minoxidil, Saline - Female Pattern Alopecia | Phase 3 | Unknown | Brasilia University Hospital | 60 | 2012-03-01 | 2013-09-25 |
| Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss 3%Minoxidil lotion, 3% Minoxidil with 0.1% Finasteride lotion - Androgenetic Alopecia | Phase 3 | Completed | Mae Fah Luang University Hospital | 40 | 2011-03-01 | 2012-07-20 |
| Clinical Trial in Females With Female Pattern Hair Loss 5% Minoxidil, 2% Minoxidil - Alopecia | Phase 3 | Completed | Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | 322 | 2010-06-01 | 2014-05-22 |
| Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia minoxidil - Androgenetic Alopecia, Female Pattern Hair Loss | Phase 3 | Completed | Charite University, Berlin, Germany | 113 | 2008-06-01 | 2011-11-18 |
| A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss minoxidil - Androgenetic Alopecia | Phase 3 | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | 352 | 2003-10-01 | 2016-09-30 |
Alopecia (16) · Hair Diseases (1) · Skin Diseases (1)
Universitas Indonesia (2) · Brasilia University Hospital (1) · Cairo University (1) · Charite University, Berlin, Germany (1) · Dr. dr. Lili Legiawati, SpKK(K) (1) · EMS (1) · Eurofarma Laboratorios S.A. (1) · Farid Masoud (1) · Industrial Farmacéutica Cantabria, S.A. (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. (1) · Mae Fah Luang University Hospital (1) · Samson Clinical Operations Pty Ltd (1) · Sheikh Zayed Federal Postgraduate Medical Institute (1) · Triple Hair Inc (1)
Brazil (3) · Germany (3) · Indonesia (3) · Canada (2) · United States (2) · Australia (1) · Egypt (1) · France (1) · Iran (1) · Italy (1) · Portugal (1) · Spain (1) · Thailand (1) · United Kingdom (1)
Barbara Uzel, M.D (1) · Bruce Kohut, DMD (1) · Chuchai Tanglertsampan, MD (1) · Clare Kendall, MA (1) · Farid Masoud, PharmD (1) · Hamideh Azimi Alamdari, MD (1) · Hanan Nada, PhD (1) · Izelda Costa, Ph.D (1) · Javad Shokri, Ph.D (1) · Kara Adistri, MD (1) · Maggie Abbassi, PhD (1) · Samar Farid, PhD (1) · Solmaz Asnaashari, Ph.D (1) · Yousef Javadzadeh, Ph.D (1)
PMID 23960389, PMID 27391640, PMID 30886475, PMID 33112463, PMID 36571611, PMID 37605227
2009 (1)